Documentation sheet
Definition of indicator
Calculation (numerator, denominator)
Additional underlying concepts
Relevant dimensions (subgroups)
Preferred data sources
Rationale
Data availability, quality and periodicity
References
Work to do
 |  |
Cancer incidence (all cancers plus nine specified cancers) Total cancer incidence and incidence of the most important cancers, per 100.000 population, in a given year. |
| |
Calculation (numerator, denominator) Number of patients with newly diagnosed cancer during the given calendar year divided by person-years at risk (specific per sex, geographical area, period and age group), expressed as per 100.000 population. The 10 categories to be included are (ICD-10): 1) all cancers combined without nonmelanoma skin (C00-C97), 2) trachea, bronchus or lung (C33-34), 3) breast (C50), 4) colorectal (C18-C21), 5) prostate (C61) , 6) stomach, 7) melanoma, 8) cervical (C53), 9) leukemias/lymphomas, 10) all childhood cancers (0-14). |
| |
| |
Relevant dimensions (subgroups) Country (also region), calendar year, age group, sex (except for cervix and prostate cancer). |
| |
|
- Original data provided by national Cancer Registries (population based or regional/locall). Cancer Registries publish incidence data with a delay of 2-5 years. - Secondary data sources are Cancer Incidence in Five Continents (CI5C), EUCAN (1998) and GLOBOCAN (2000 and 2002) databases (International Agency on Research on Cancer; www-dep.iarc.fr) - Eurostat, WHO or OECD all derive their figures from EUCAN and GLOBOCAN |
| |
|
Cancer is one of the most important causes of death and it is related to a high disease burden in Europe and there are (often) prevention possibilities. Therefore cancer monitoring is an important Public Health issue. |
| |
Data availability, quality and periodicity - Cancer Incidence in Five Continents (CI5C; VIIIth edition): data for 29 European countries. Population based data for Denmark, Estonia, Finland, Iceland, (Ireland), Malta, Norway, Slovakia, Slovenia, Sweden. - EUCAN database (version 5, 1998) with estimates (last available incidence year: 1998) for the following countries: Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Netherlands, Portugal, Spain, Sweden, and United Kingdom. - GLOBOCAN (2000 and 2002) for ? - In some MSs Cancer Registry covers the entire population, in others one ore more Cancer Registries cover a fraction of the population. The European Network of Cancer Registries (ENCR) and the International Agency on Research on Cancer (IARC) produces cancer incidence estimates at national level, where missing, by mathematical models. |
| |
|
- EUCAN database (International Agency on Research on Cancer) - Ferlay, F. Bray, R. Sankila and D.M. Parkin. EUCAN: Cancer Incidence, Mortality and Prevalence in the European Union 1997. - The European Network of Cancer Registries, ENCR |
| |
|
ECHIM decision is to include all cancers + 9 nine specified cancers cancers (as suggested by WP Morbidity & Mortality; Eurochip) |
Data Presentations
More indicator information will follow in due time. |
<p class=\'alertDesc\'>
What the indicator is meant to measure. If not unambiguous, all acceptable alternatives are to be listed in numbered preference order. The final decision on preference order/numbering is to be made by ECHIM coregroup.
</p>
</p>
','../images/definition_1.gif');){kind=link}
<p class=\'alertDesc\'>
How to calculate the indicator (method, numerator, denominator, etc), in the same preference order as above if more than one alternative.
</p>
</p>
','../images/definition_1.gif');){kind=link}
<p class=\'alertDesc\'>
Why the indicator is measured the chosen way (prevalence, incidence, mortality, absolute numbers etc.)? Also reasons for the preferred definition and calculation details can be included here.
</p>
</p>
','../images/definition_1.gif');){kind=link}
)
<p class=\'alertDesc\'>
Should the indicator be stratified by e.g. age, gender, socio-economic status and area
</p>
</p>
','../images/definition_1.gif');){kind=link}
<p class=\'alertDesc\'>
The type of data source; in the same preference order as above (typically either register data or HIS/HES).
</p>
</p>
','../images/definition_1.gif');){kind=link}
<p class=\'alertDesc\'>
Why is this indicator important, from the public health point of view. (For example: size or dynamics of the problem/issue, evidence of the relevance of the issue in public health terms (for determinants) or evidence of intervention effectiveness (for prevention or care issues)).
</p>
</p>
','../images/definition_1.gif');){kind=link}
<p class=\'alertDesc\'>
The recommended data source (e.g. Eurostat, OECD, WHO, national registers or HIS/HES, project databases etc.), in the same preference order as above; some notes on the quality and availability of the data for the indicator. Eventually, also information on the availability in coutries, as derived from the ECHIM survey.
</p>
</p>
','../images/definition_1.gif');){kind=link}
<p class=\'alertDesc\'>
References to original publications, websites, EHIS-question/naire, PHP projects, etc.
</p>
</p>
','../images/definition_1.gif');){kind=link}
<p class=\'alertDesc\'>
What should be done to improve and complete this sheet. Eventually, this cell should be blank.
</p>
</p>
','../images/definition_1.gif');){kind=link}